Your browser doesn't support javascript.
loading
Targeting CD157 in AML using a novel, Fc-engineered antibody construct.
Krupka, Christina; Lichtenegger, Felix S; Köhnke, Thomas; Bögeholz, Jan; Bücklein, Veit; Roiss, Michael; Altmann, Torben; Do, To Uyen; Dusek, Rachel; Wilson, Keith; Bisht, Arnima; Terrett, Jon; Aud, Dee; Pombo-Villar, Esteban; Rohlff, Christian; Hiddemann, Wolfgang; Subklewe, Marion.
Afiliação
  • Krupka C; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.
  • Lichtenegger FS; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.
  • Köhnke T; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany.
  • Bögeholz J; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.
  • Bücklein V; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.
  • Roiss M; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany.
  • Altmann T; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.
  • Do TU; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.
  • Dusek R; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany.
  • Wilson K; Department of Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Bisht A; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.
  • Terrett J; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.
  • Aud D; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany.
  • Pombo-Villar E; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.
  • Rohlff C; Clinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich, Munich, Germany.
  • Hiddemann W; Laboratory of Translational Cancer Immunology, Gene Center Munich, Ludwig-Maximilians-University Munich, Germany.
  • Subklewe M; Department of Internal Medicine III, Klinikum of The LMU Munich, Munich, Germany.
Oncotarget ; 8(22): 35707-35717, 2017 May 30.
Article em En | MEDLINE | ID: mdl-28415689
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Leucemia Mieloide Aguda / ADP-Ribosil Ciclase / Terapia de Alvo Molecular / Antineoplásicos Imunológicos / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Leucemia Mieloide Aguda / ADP-Ribosil Ciclase / Terapia de Alvo Molecular / Antineoplásicos Imunológicos / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha